Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil for lower urinary tract symptoms secondary to benign prostatic hyperplasia
IRCT201008094541N1Phase 3Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of tadalafil in benign prostatic hyperplasia (BPH), sponsored by Guilan University of Medical Sciences. Started Feb 2009; status: completed.
02
Drugs
tadalafil
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on IRCT201008094541N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201008094541N1.